252 related articles for article (PubMed ID: 12554828)
1. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
Dolder CR; Lacro JP; Jeste DV
Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
Dolder CR; Lacro JP; Dunn LB; Jeste DV
Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
[TBL] [Abstract][Full Text] [Related]
3. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
Doshi JA; Li P; Desai S; Marcus SC
J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
[TBL] [Abstract][Full Text] [Related]
4. Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.
Nelson LA; Graham MR; Lindsey CC; Rasu RS
Psychosomatics; 2011; 52(4):310-8. PubMed ID: 21777713
[TBL] [Abstract][Full Text] [Related]
5. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
6. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
[TBL] [Abstract][Full Text] [Related]
7. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.
Menzin J; Boulanger L; Friedman M; Mackell J; Lloyd JR
Psychiatr Serv; 2003 May; 54(5):719-23. PubMed ID: 12719504
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral diabetes medications among users and nonusers of antipsychotic medication.
Desai PR; Adeyemi AO; Richards KM; Lawson KA
Psychiatr Serv; 2014 Feb; 65(2):215-20. PubMed ID: 24233254
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
[TBL] [Abstract][Full Text] [Related]
10. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
11. Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.
Alene M; Wiese MD; Angamo MT; Bajorek BV; Yesuf EA; Wabe NT
BMC Clin Pharmacol; 2012 Jun; 12():10. PubMed ID: 22709356
[TBL] [Abstract][Full Text] [Related]
12. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?
Kreyenbuhl J; Dixon LB; McCarthy JF; Soliman S; Ignacio RV; Valenstein M
Schizophr Bull; 2010 Mar; 36(2):428-35. PubMed ID: 18718883
[TBL] [Abstract][Full Text] [Related]
13. Role of patient experience in atypical antipsychotic adherence: a retrospective data analysis.
Vanelli M; Coca-Perraillon M; Troxell-Dorgan A
Clin Ther; 2007 Dec; 29(12):2768-73. PubMed ID: 18201595
[TBL] [Abstract][Full Text] [Related]
14. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
Nakonezny PA; Byerly MJ
Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
[TBL] [Abstract][Full Text] [Related]
15. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
17. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
20. The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia.
Nakonezny PA; Byerly MJ; Pradhan A
Psychiatry Res; 2013 Jun; 208(1):9-14. PubMed ID: 23473653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
